IC
Ionetix Corp / DE /
SEC filingPharmaceuticals · Lansing, MI
Amount raised$32.3Msold at filing
Total offering$32.3M
Investors in the raise267count reported to the SEC
FiledApr 23, 2026first sale Apr 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Douglas BootheDirector
Gregory MartinDirector
David LandskowskyDirector
Phieu PhunExecutive Officer
Michael StewartExecutive Officer, Director
Kevin CameronExecutive Officer
Executive officers, directors and promoters as listed on the Form D.